Literature DB >> 2510169

Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.

J K Batra1, Y Jinno, V K Chaudhary, T Kondo, M C Willingham, D J FitzGerald, I Pastan.   

Abstract

LysPE40 is a modified form of Pseudomonas exotoxin that lacks the cell-binding domain and has a chemically reactive lysine residue near the amino terminus. LysPE40 is made in Escherichia coli and secreted into the medium from which it is readily purified. Two immunotoxins were constructed by coupling LysPE40 to an antibody to the human transferrin receptor (TFR) or to an antibody to the human interleukin-2 receptor. These immunotoxins were selectively cytotoxic to receptor-bearing cells in tissue culture. Anti-TFR-LysPE40 given intraperitoneally to mice appeared rapidly in the blood and caused regression of A431 tumors growing as subcutaneous xenografts. These results show that it is possible to cause regression of a solid carcinoma by an immunotoxin if proper targeting can be achieved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510169      PMCID: PMC298319          DOI: 10.1073/pnas.86.21.8545

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  20 in total

Review 1.  Redesigning nature's poisons to create anti-tumor reagents.

Authors:  E S Vitetta; R J Fulton; R D May; M Till; J W Uhr
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

2.  Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin.

Authors:  B J Bourrie; P Casellas; H E Blythman; F K Jansen
Journal:  Eur J Biochem       Date:  1986-02-17

3.  An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.

Authors:  C F Scott; V S Goldmacher; J M Lambert; J V Jackson; G D McIntyre
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

4.  Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.

Authors:  D C Blakey; G J Watson; P P Knowles; P E Thorpe
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

5.  Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model.

Authors:  R K Chiou; R L Vessella; C Limas; R B Shafer; M K Elson; E W Arfman; P H Lange
Journal:  Cancer       Date:  1988-05-01       Impact factor: 6.860

6.  Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer.

Authors:  D J FitzGerald; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 12.779

7.  Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model.

Authors:  M C Willingham; D J FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 12.779

8.  Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

Authors:  J Hwang; D J Fitzgerald; S Adhya; I Pastan
Journal:  Cell       Date:  1987-01-16       Impact factor: 66.850

9.  Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin.

Authors:  V K Chaudhary; D J FitzGerald; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 12.779

10.  Role of domain II of Pseudomonas exotoxin in the secretion of proteins into the periplasm and medium by Escherichia coli.

Authors:  V K Chaudhary; Y H Xu; D FitzGerald; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 12.779

View more
  17 in total

1.  Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.

Authors:  D Rathore; J K Batra
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

Review 2.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

Review 3.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843

4.  Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections.

Authors:  U Brinkmann; J Buchner; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 12.779

5.  Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.

Authors:  W Debinski; B Karlsson; L Lindholm; C B Siegall; M C Willingham; D FitzGerald; I Pastan
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 19.456

6.  The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.

Authors:  R J Kreitman; V K Chaudhary; T Waldmann; M C Willingham; D J FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 12.779

7.  Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).

Authors:  J K Batra; D J Fitzgerald; V K Chaudhary; I Pastan
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 5.069

8.  Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.

Authors:  J K Batra; P G Kasprzyk; R E Bird; I Pastan; C R King
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 12.779

9.  Use of high density cultures of Escherichia coli for high level production of recombinant Pseudomonas aeruginosa exotoxin A.

Authors:  R Fass; M van de Walle; A Shiloach; A Joslyn; J Kaufman; J Shiloach
Journal:  Appl Microbiol Biotechnol       Date:  1991-10       Impact factor: 5.560

10.  B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.

Authors:  U Brinkmann; L H Pai; D J FitzGerald; M Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.